May 30 2012
The 8th NanoBio-Europe conference will take place on 18 - 20 June 2012 in Varese (Lombardy, Northern Italy), showcasing the latest international developments in nanobiotechnology, and providing a platform to facilitate interdisciplinary communications, new collaborations for delegates from academic, industrial and clinical backgrounds. Following the success of previous NanoBioEurope conferences in Barcelona (2008), Grenoble (2009), Muenster (2010) and Cork (2011), the 8th NanoBio-Europe International Congress & Exhibition on Nanobiotechnology will take place from 18th to 20th June 2012 and is expected to gather more than 250 scientists and researcher specialised in NanoBiotechnology.
Nanobiotechnology is one of the most fascinating and challenging fields of research and development. It is highly multidisciplinary, involving research from all scientific and engineering disciplines, together with relevant clinical expertise as applicable. As such, nanobiotechnology provides great opportunities for innovation through converging of knowledge in materials, photonics, electronics, biology and medicine, with technology-driven and application-driven approaches.
The major focus of the NanoBio-Europe Conference is on medical and biological applications of nanobiotechnology, in which nanotechnology-enabled devices and systems could provide the basis for better, more accessible healthcare and testing strategies with improved outcomes for the citizen.
Keynote speakers who are global experts in selected fields of nanobiotechnology will present some exciting recent developments and their future visions within each session. There will also be a special session with keynote presentations from some of the international experts in nanobiotechnology based in Italy.
The conference is organised by the European Commission's Joint Research Centre (JRC) and Fondazione Don Gnocchi. The JRC that has many years of experience in the field of nanotechnology and nano biotechnology. Multidisciplinary, multinational team of scientists performs research in the safety assessment of nanomaterials, bio/non-bio interfaces, protein surface interactions and biosensing and biodetection systems and devices.